Dose-dependent mobilisation of haematopoietic progenitor cells in healthy volunteers receiving glycosylated rHuG-CSF

Bone Marrow Transplantation

Volumn 18, Issue 1, 1996, Pages 19-27

  Hoglund M ^a   Smedmyr, B ^a   Simonsson, B ^a   Totterman T ^a   Bengtsson, M ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Allogeneic transplantation; CD34+ subsets; Dose response; G CSF; Mobilisation; PBPC

Indexed keywords

CD33 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; HLA DR ANTIGEN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ANALGESIA; ARTICLE; BONE PAIN; BURST FORMING UNIT E; CELL COUNT; CELL MOTILITY; CLINICAL TRIAL; COLONY FORMING UNIT; COLONY FORMING UNIT GM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG TOLERABILITY; FLOW CYTOMETRY; HEADACHE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMUNOPHENOTYPING; LEUKAPHERESIS; LEUKOCYTE COUNT; LIVER DYSFUNCTION; LYMPHOCYTE COUNT; MALAISE; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; T LYMPHOCYTE;

ADULT; ANTIGENS, CD; ANTIGENS, CD34; ANTIGENS, CD45; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; ANTIGENS, THY-1; BONE MARROW; BONE MARROW CELLS; COLONY-FORMING UNITS ASSAY; DOSE-RESPONSE RELATIONSHIP, DRUG; GLYCOSYLATION; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELLS; HLA-DR ANTIGENS; HUMANS; IMMUNOPHENOTYPING; MALE; PILOT PROJECTS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECOMBINANT PROTEINS; SAFETY;

EID: 0029781776     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Kessinger A, Smith DM, Strandjord SE et al. Allogeneic transplantation of blood-derived, T-cell depleted hemopoietic stem cells after myeloablative treatment in a patient with acute lymphoblastic leukemia. Bone Marrow Transplant 1989; 4: 643-646.
2. Körbling M, Przepiorka D, Huh YO et al. Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts. Blood 1995; 85: 1659-1665.
3. Schmitz N, Dreger P, Suttorp M et al. Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor). Blood 1995; 85: 1666-1672.
4. Bensinger WI, Weaver CH, Appelbaum FR et al. Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Blood 1995; 85: 1655-1658.
5. Sheridan WP, Begley CG, Juttner CA et al. Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet 1992; 339: 640-644.
6. Lane T, Law P, Maruyama M et al. Harvesting and enrichment of hematopoietic progenitor cells mobilized into the peripheral blood of normal donors by granulocyte-macrophage colony-stimulating factor (GM-CSF) or G-CSF: potential role in allogeneic marrow transplantation. Blood 1995; 85: 275-282.
7. Russell JA, Luider J, Weaver M et al. Collection of progenitor cells for allogeneic transplantation from peripheral blood of normal donors. Bone Marrow Transplant 1995; 15: 111-115.
8. Tabilio A, Falzetti F, Aversa F et al. Mobilization and collection of hematopoietic progenitor cells (PBSC) from peripheral blood of normal donors. Blood 1994; 84 (Suppl. 1): 350a, 1387.
9. Goldman J. Peripheral blood stem cells for allografting. Blood 1995; 85: 1413-1415.
10. Dührsen U, Villeval J-L, Boyd J et al. Effects of recombinant human granulocyte colony-stimulating factor on hematopoietic progenitor cells in cancer patients. Blood 1988; 72: 2074-2081.
11. Stoppa AM, Blaise D, Viens P et al. Phase I study of in vivo lenograstim (rHuG-CSF) for stem cell collection demonstrates improved neutrophil recovery after autologous bone marrow transplantation. Bone Marrow Transplant 1994; 13: 541-547.
12. Matsunaga T, Sakamaki S, Kongo Y et al. Recombinant human granulocyte colony-stimulating factor can mobilize sufficient amounts of peripheral blood stem cells in healthy volunteers for allogeneic transplantation. Bone Marrow Transplant 1993; 11: 103-108.
13. Sato N, Sawada K, Takahashi T et al. A time course study for optimal harvest of peripheral blood progenitor cells by granulocyte colony-stimulating in healthy volunteers. Exp Hematol 1994; 22: 973-978.
14. Houston AC, Stevens LA. An open randomised study of the pharmacokinetics of lenograstim (glycosylated recombinant human granulocyte colony-stimulating factor; rHuG-CSF) in healthy male volunteers. Br J Clin Pharmacol (in press).
15. Kernan N, Collins N, Juliano L et al. Clonable T lymphocytes in T cell-depleted bone marrow transplants correlate with development of graft-v-host disease. Blood 1986; 68: 770-773.
16. Civin C, Strauss L, Brovall C et al. Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells. J Immunol 1984; 133: 157-165.
17. Sutherland HJ, Eaves CJ, Eaves AC et al. Characterization and partial purification of human marrow cells capable of initiating long-term hematopoiesis in vitro. Blood 1989; 74: 1563-1570.
18. Bender J, Unverzagt K, Walker D et al. Identification and comparison of CD34-positive cells and their subpopulations from normal peripheral blood and bone marrow using multicolor flow cytometry. Blood 1991; 77: 2591-2596.
19. Siena S, Bregni M, Brando B et al. Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood 1991; 77: 400-409.
20. + cells in apheresis products from patients mobilized for peripheral blood progenitors wih different regimens. Bone Marrow Transplant 1994; 13: 479-485.
21. Bensinger WI, Longin K, Appelbaum F et al. Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony stimulating factor (rhG-CSF): an analysis of factors correlating with the tempo of engraftment after transplantation. Br J Haematol 1994; 87: 825-831.
22. + cell analysis: technical recommendations for progenitor estimation in leukapheresis from multiple myeloma patients. J Hematother 1995; 4: 21-28.
23. Schwartzberg L, Birch R, Blanco R et al. Rapid and sustained hematopoietic reconstitution by peripheral blood stem cell infusion alone following high-dose chemotherapy. Bone Marrow Transplant 1993; 11: 369-374.
24. + cells immunoselected from G-CSF-mobilized peripheral blood progenitor cells of the marrow donor. Bone Marrow Transplant 1994; 14: 791-797.
25. + selected progenitor cells from matched related donors: results of a clinical phase I/II study. Blood 1995; 86 (Suppl. 1): 290a, 1148.
26. Aversa F, Tabilio A, Terenzi A et al. Successful engraftment of T-cell-depleted haploidentical 'three-loci' incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum. Blood 1994; 84: 3948-3955.
27. Russell NH, Hunter AE. Peripheral blood stem cells for allogeneic transplantation. Bone Marrow Transplant 1994; 13: 353-355.
28. Verfaillie C, Blakholmer K, McGlave P. Purified primitive human hematopoietic progenitors with long-term in vitro repopulating capacity adhere selectively to irradiated bone marrow stroma. J Exp Med 1990; 172: 509-520.
29. - progenitor cells. Blood 1991; 77: 1218-1227.
30. + myeloid progenitors using CD45-RA analysis. Blood 1993; 81: 2301-2309.
31. Craig W, Poppema S, Little M-T et al. CD45 isoform expression on human haemopoietic cells at different stages of development. Br J Haematol 1994; 88: 24-30.
32. Andrews R, Singer J, Bernstein I. Precursors of colony-forming cells in humans can be distinguished from colony-forming cells by expression of the CD33 and CD34 antigens and light scatter properties. J Exp Med 1989; 169: 1721-1731.
33. Craig W, Kay R, Cutler RL, Lansdorp PM. Expression of Thy-1 on human hematopoietic progenitor cells. J Exp Med 1993; 177: 1331-1342.
34. - subpopulation from mobilized peripheral blood. Blood 1995; 85: 368-378.
35. Baum CM, Weissman I, Tsukamoto A et al. Isolation of a candidate human hematopoietic stem-cell population. Proc Natl Acad Sci USA 1992; 89: 2804-2808.
36. Hohaus S, Goldschmidt H, Ehrhardt R, Haas R. Successful autografting following myeloablative conditioning therapy with blood stem cells mobilized by chemotherapy plus rhG-CSF. Exp Hematol 1993; 21: 508-514.
37. Fukuda T, Okamura S, Shimoda K et al. Predominance of myeloid antigens in CD34-positive peripheral blood stem cells over those in bone marrow after administration of granulocyte colony-stimulating factor. Eur J Haematol 1994; 52: 201-206.
38. Inaba T, Shimazaki C, Hirata T et al. Phenotypic differences of CD34-positive stem cells harvested from peripheral blood and bone marrow obtained before and after peripheral blood stem cell collection. Bone Marrow Transplant 1994; 13: 527-532.
39. + cells with a different antigenic profile compared with use during steady-state hematopoiesis. Bone Marrow Transplant 1994; 14: 827-832.
40. + cells. Blood 1994; 84: 2930-2939.
41. Mercolino TJ, Connelly MC, Meyer EJ et al. Immunologic differentiation of absolute lymphocyte count with an integrated flow cytometric system: a new concept for absolute T cell subset determinations. Cytometry 1995; 22: 48-59.
42. + cell estimation in peripheral blood for autografting in patients with cancer. In: Wunder E, Sovalat H, Hénon P, Serke S (eds). Hematopoietic Stem Cells. The Mulhouse Manual. AlphaMed Press: Dayton, Ohio, 1994, pp 23-30.
43. Drize N, Gan O, Zander A. Effect of recombinant human granulocyte colony-stimulating factor treatment of mice on spleen colony-forming unit number and self-renewal capacity. Exp Hematol 1993; 21: 1289-1293.
44. Roberts AW, Metcalf D. Granulocyte colony-stimulating factor induces selective elevations of progenitor cells in the peripheral blood of mice. Exp Hematol 1994; 22: 1156-1163.
45. Dreger P, Haferlach T, Eckstein V et al. G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: safety, kinetics of mobilization, and composition of the graft. Br J Haematol 1994; 87: 609-613.
46. Chatta G, Price T, Allen R, Dale D. Effects of in vivo recombinant methionyl human granulocyte colony-stimulating factor on the neutrophil response and peripheral blood colony-forming cells in healthy young and elderly adult volunteers. Blood 1994; 84: 2923-2929.
47. Weaver CH, Longin K, Buckner C, Bensinger W. Lymphocyte content in peripheral blood mononuclear cells collected after the administration of recombinant human granulocyte colony-stimulating factor. Bone Marrow Transplant 1994; 13: 411-415.
48. Molineux G, Pojda Z, Hampson IN et al. Transplantation potential of peripheral blood stem cells induced by granulocyte colony-stimulating factor. Blood 1990; 76: 2153-2158.
49. Pettengell R, Testa N, Swindell R et al. Transplantation potential of hematopoietic cells released into the circulation during routine chemotherapy for non-Hodgkin's lymphoma. Blood 1993; 82: 2239-2248.
50. + peripheral blood cells from healthy adults mobilized by recombinant human granulocyte colony-stimulating factor. Blood 1994; 84: 2795-2801.